Raizer, J J <br/><br/>
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.  [electronic resource] 

 -  Journal of neuro-oncology  Jan 2005 
 - 173-80 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0167-594X 
<br/><br/><label>Standard No.: </label>10.1007/s11060-004-1360-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Aspartic Acid--analogs & derivatives<br/>Central Nervous System Neoplasms--diagnosis<br/>Choline--metabolism<br/>Creatine--metabolism<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Immunocompetence<br/>Lactic Acid--metabolism<br/>Lipid Metabolism<br/>Lymphoma--diagnosis<br/>Magnetic Resonance Imaging<br/>Magnetic Resonance Spectroscopy--standards<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Protons<br/>Survival Analysis